In the game of tug of war, will it be clinical or revenue integrity staff members who stand up to the challenge? When it comes to charge capture, it can be a struggle to know who should be held accountable. Read More »
Despite opposition from many stakeholders, a bipartisan contingent of Congress, and CMS’ own advisory panel,the agency is moving forward with its plan to drastically cut payments for drugs acquired through the 340B drug discount program, according to the 2018 OPPS final rule, released November 1...Read More »
Thank you to everyone who joined us October 23–24 at the 2017 Revenue Integrity Symposium in Franklin, Tennessee. We enjoyed connecting with current and future NAHRI members in the exhibit hall and conference sessions. Read More »
The methods for maximizing revenue capture have changed over the years. Revenue management has evolved from random chart audits to using data analytics and technology to find patterns.Read More »
